Clindamycin/benzoyl peroxide gel (BenzaClin®): A review of its use in the management of acne

American Journal of Clinical Dermatology

Volumn 9, Issue 3, 2008, Pages 193-204

  McKeage, Kate ^a,b   Keating, Gillian M ^a,b  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

^b WOLTERS KLUWER HEALTH   (United States)

Author keywords

Acne vulgaris, treatment; Adis Drug Evaluations; Benzoyl peroxide clindamycin, therapeutic use

Indexed keywords

ANTI ACNE AGENT; BENZACLIN; BENZOIC ACID; BENZOYL PEROXIDE; BENZOYL PEROXIDE PLUS CLINDAMYCIN; BENZOYL PEROXIDE PLUS ERYTHROMCYIN; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CLINDAMYCIN PLUS TRETINOIN; DODECYL SULFATE SODIUM; DUAC; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACNE; ACNE VULGARIS; ANTIINFLAMMATORY ACTIVITY; APPLICATION SITE BURNING; APPLICATION SITE DRYNESS; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PEELING; CLINICAL TRIAL; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXPOSURE; DRUG FORMULATION; DRUG METABOLISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; EVENING DOSAGE; GEL; HUMAN; INJECTION SITE ERYTHEMA; MORNING DOSAGE; NEUTROPHIL; NONHUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSEUDOMEMBRANOUS COLITIS; QUALITY OF LIFE; REVIEW; SKIN IRRITATION; TREATMENT RESPONSE;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CLINDAMYCIN; DRUG COMBINATIONS; GELS; HUMANS; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 42449161418     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200809030-00010     Document Type: Review

References (40)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 1998; 39 (2 Pt 3): S34-7
2. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1-37
3. Taylor GA, Shalita AR. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. Am J Clin Dermatol 2004; 5 (4): 261-5
4. Feldman S, Careccia RE, Barham KL, et al. Diagnosis and treatment of acne. Am Fam Physician 2004 May 1; 69 (9): 2123-30
5. Warner GT, Plosker GL. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. Am J Clin Dermatol 2002; 3 (5): 349-60
6. Dermik Laboratories. BenzaClin® topical gel (clindamycin-benzoyl peroxide gel): prescribing information [online]. Available from URL: http://www.dermik.com [Accessed 2007 Jun 12]
7. Antibacterials. In: McEvoy GK, editor. AHFS drug information. Bethesda (MD): American Society of Health-Sytem Pharmacists, Inc., 2007: 3437-42
8. Burkhart CN, Specht K, Neckers D. Synergistic activity of benzoyl peroxide and erythromycin. Skin Pharmacol Appl Skin Physiol 2000 Sep; 13 (5): 292-6
9. Gans EH, Kligman AM. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. J Dermatolog Treat 2002 Sep; 13 (3): 107-10
10. Cunliffe WJ, Holland KT, Bojar R, et al. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther 2002 Jul; 24 (7): 1117-33
11. Leyden J, Kaidbey K, Levy SF. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes: an in vivo comparative study. Am J Clin Dermatol 2001; 2 (4): 263-6
12. Leyden JJ. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Cutis 2002 Jun; 69 (6): 475-80
13. Eady EA, Farmery MR, Ross JI, et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994; 131 (3): 331-6
14. Farmery MR, Jones CE, Eady EA, et al. In vitro activity of azelaic acid, benzoyl peroxide and zinc acetate against antibiotic-resistant propionibacteria from acne patients. J Dermatol Treat 1994 Jun; 5: 63-5
15. Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995 Aug; 33 (2 Pt. 1): 247-53
16. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1978 Jan; 70 (1): 51-5
17. Leeming JP, Holland KT, Cunliffe WJ. The pathological and ecological significance of microorganisms colonising acne vulgaris comedones. J Med Microbiol 1985; 20: 11-6
18. Hegemann L, Toso SM, Kitay K, et al. Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol 1994 May; 130: 569-75
19. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003; 42 (14): 1287-304
20. Levy S. Dermatopharmacology of a new combination gel formulation for the topical treatment of acne. Cutis 2001 Feb; 67 (2 Suppl.): 8-12
21. Eller MG, Smith RB, Phillips JP. Absorption kinetics of topical clindamycin preparations. Biopharm Drug Dispos 1989; 10 (5): 505-12
22. Decker LC, Deuel DM, Sedlock DM. Role of lipids in augmenting the antibacterial activity of benzoyl peroxide against Propionibacterium acnes. Antimicrob Agents Chemother 1989 Mar; 33 (3): 326-30
23. Nacht S, Yeung D, Beasley Jr JN, et al. Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol 1981 Jan; 4 (1): 31-7
24. Yeung D, Nacht S, Bucks D, et al. Benzoyl peroxide: percutaneous penetration and metabolic disposition: II. Effect of concentration. J Am Acad Dermatol 1983 Dec; 9 (6): 920-4
25. Amr S, Brown MB, Martin GP, et al. Activation of clindamycin phosphate by human skin. J Appl Microbiol 2001 Apr; 90 (4): 550-4
26. Leyden JJ, Berger RS, Dunlap FE, et al. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatment of acne vulgaris. Am J Clin Dermatol 2001; 2 (1): 33-9
27. Tschen EH, Katz HI, Jones TM, et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 2001 Feb; 67 (2): 165-9
28. Leyden JJ, Hickman JG, Jarratt MT, et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001 Jan; 5 (1): 37-42
29. Bowman S, Gold M, Nasir A, et al. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. J Drugs Dermatol 2005; 4 (5): 611-8
30. Weiss J, Shavin J, Davis MW. Overall results of the BEST study following treatment of patients with mild to moderate acne. Cutis 2003 Feb; 71 (2 Suppl.): 10-7
31. Rist T, Davis MW. Study design and selection criteria in the BEST study. Cutis 2003 Feb; 71 (2 Suppl.): 5-9
32. Fernandez-Obregon A, Davis MW. The BEST study: evaluating efficacy by selected demographic subsets. Cutis 2003 Feb; 71 (2 Suppl.): 18-26
33. Rodriguez D, Davis MW. The BEST study: results according to prior treatment. Cutis 2003 Feb; 71 (2 Suppl.): 27-34
34. Fagundes DS, Fraser JM, Klauda HC. Difference in the irritation potential and cosmetic acceptability of two combination topical acne gels: combined results of two comparative studies. Today's Ther Trends 2003; 21 (3): 269-75
35. Dosik JS, Vamvakias G. A 21-day, randomized, controlled study comparing the irritation potential of two combination acne products in healthy volunteers using a cumulative irritant patch design. Am J Clin Dermatol. In press
36. Zhen Y, Stoudemayer M, Vamvakias G, et al. Pilot investigation of the hydrating effects of topical acne medications. J Drugs Dermatol 2007 Aug; 6 (8): 810-6
37. Fried RG, Werschler WP, Vamvakias G. Comparison of patients preferences between two gel delivery systems for clindamycin/benzoyl peroxide treatment of acne vulgaris [poster]. 31st Skin Disease Education Foundation, Dermatology Seminar; 2007 Mar 3; Maui (HI)
38. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003; 49 (3 Suppl.): S200-10
39. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007 Apr; 56 (4): 651-63
40. Dreno B. Topical antibacterial therapy for acne vulgaris. Drugs 2004; 64 (21): 2389-97